TY - JOUR
T1 - An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
AU - MalariaGEN
AU - Adam, Ishag
AU - Alam, Mohammad Shafiul
AU - Alemu, Sisay
AU - Amaratunga, Chanaki
AU - Amato, Roberto
AU - Andrianaranjaka, Voahangy
AU - Anstey, Nicholas M.
AU - Aseffa, Abraham
AU - Ashley, Elizabeth
AU - Assefa, Ashenafi
AU - Auburn, Sarah
AU - Barber, Bridget E.
AU - Barry, Alyssa
AU - Batista Pereira, Dhelio
AU - Cao, Jun
AU - Chau, Nguyen Hoang
AU - Chotivanich, Kesinee
AU - Chu, Cindy
AU - Dondorp, Arjen M.
AU - Drury, Eleanor
AU - Echeverry, Diego F.
AU - Erko, Berhanu
AU - Espino, Fe
AU - Fairhurst, Rick
AU - Faiz, Abdul
AU - Fernanda Villegas, María
AU - Gao, Qi
AU - Golassa, Lemu
AU - Goncalves, Sonia
AU - Grigg, Matthew J.
AU - Hamedi, Yaghoob
AU - Hien, Tran Tinh
AU - Htut, Ye
AU - Johnson, Kimberly J.
AU - Karunaweera, Nadira
AU - Khan, Wasif
AU - Krudsood, Srivicha
AU - Kwiatkowski, Dominic P.
AU - Lacerda, Marcus
AU - Ley, Benedikt
AU - Lim, Pharath
AU - Liu, Yaobao
AU - Llanos-Cuentas, Alejandro
AU - Lon, Chanthap
AU - Lopera-Mesa, Tatiana
AU - Marfurt, Jutta
AU - Michon, Pascal
AU - Miotto, Olivo
AU - Mohammed, Rezika
AU - Mueller, Ivo
N1 - Publisher Copyright: © 2022 MalariaGEN et al.
PY - 2022
Y1 - 2022
N2 - This report describes the MalariaGEN Pv4 dataset, a new release of curated genome variation data on 1,895 samples of Plasmodium vivax collected at 88 worldwide locations between 2001 and 2017. It includes 1,370 new samples contributed by MalariaGEN and VivaxGEN partner studies in addition to previously published samples from these and other sources. We provide genotype calls at over 4.5 million variable positions including over 3 million single nucleotide polymorphisms (SNPs), as well as short indels and tandem duplications. This enlarged dataset highlights major compartments of parasite population structure, with clear differentiation between Africa, Latin America, Oceania, Western Asia and different parts of Southeast Asia. Each sample has been classified for drug resistance to sulfadoxine, pyrimethamine and mefloquine based on known markers at the dhfr, dhps and mdr1 loci. The prevalence of all of these resistance markers was much higher in Southeast Asia and Oceania than elsewhere. This open resource of analysis-ready genome variation data from the MalariaGEN and VivaxGEN networks is driven by our collective goal to advance research into the complex biology of P. vivax and to accelerate genomic surveillance for malaria control and elimination.
AB - This report describes the MalariaGEN Pv4 dataset, a new release of curated genome variation data on 1,895 samples of Plasmodium vivax collected at 88 worldwide locations between 2001 and 2017. It includes 1,370 new samples contributed by MalariaGEN and VivaxGEN partner studies in addition to previously published samples from these and other sources. We provide genotype calls at over 4.5 million variable positions including over 3 million single nucleotide polymorphisms (SNPs), as well as short indels and tandem duplications. This enlarged dataset highlights major compartments of parasite population structure, with clear differentiation between Africa, Latin America, Oceania, Western Asia and different parts of Southeast Asia. Each sample has been classified for drug resistance to sulfadoxine, pyrimethamine and mefloquine based on known markers at the dhfr, dhps and mdr1 loci. The prevalence of all of these resistance markers was much higher in Southeast Asia and Oceania than elsewhere. This open resource of analysis-ready genome variation data from the MalariaGEN and VivaxGEN networks is driven by our collective goal to advance research into the complex biology of P. vivax and to accelerate genomic surveillance for malaria control and elimination.
KW - Data resource
KW - Genomic epidemiology
KW - Genomics
KW - Malaria
KW - Plasmodium vivax
UR - http://www.scopus.com/inward/record.url?scp=85131082443&partnerID=8YFLogxK
U2 - https://doi.org/10.12688/wellcomeopenres.17795.1
DO - https://doi.org/10.12688/wellcomeopenres.17795.1
M3 - Article
C2 - 35651694
VL - 7
JO - Wellcome Open Research
JF - Wellcome Open Research
SN - 2398-502X
M1 - 136
ER -